Oncology
George Demetri, MD
Professor of Medicine, Harvard Medical School; Director, Sarcoma Center, Dana-Farber Cancer Institute; Senior Vice President for Experimental Therapeutics, Dana-Farber Cancer Institute; Co-Director, Ludwig Center at Dana-Farber/Harvard
George D. Demetri, MD, is a renowned medical oncologist specializing in sarcomas, particularly gastrointestinal stromal tumors (GIST), bone sarcomas, and soft tissue sarcomas. As director of the Sarcoma Center at Dana-Farber Cancer Institute, he leads one of the world's largest and most respected sarcoma programs. Dr. Demetri pioneered the development of imatinib mesylate (Gleevec), the first targeted therapy for GIST, revolutionizing treatment for this formerly rapidly fatal disease and achievi
40+
Years in Practice
Credentials
Board Certifications
- Medical Oncology, 1989
- Internal Medicine, 1986
Education & Training
- Stanford University School of Medicine — M.D., 1983
- University of Washington Hospitals — Residency, Internal Medicine
- Dana-Farber Cancer Institute — Fellowship, Hematology & Oncology
Peer Recognition
2023
Recognition & Leadership
Awards & Honors
- Focused Giving Program Award, Johnson and Johnson Foundation 1993
- Emil J. Freireich Award in Clinical Cancer Research 2002
- Claire W. and Richard P. Morse Research Award 2005
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Massachusetts General Hospital
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
Languages
English
Experience
40+ years in practice